Clinical trials
Patient Participation clinical trials
Below are recruiting patient participation clinical trials, each written for real people, not researchers. We’re tracking 85 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT00992303Recruiting
Collecting tissue samples during radiation for people with cancer
This study collects tissue samples from people with cancer while they are getting radiation therapy. It also includes healthy participants, to help researchers compare samples and better understand cancer and treatment.
Dallas, TexasAges 18 years+ - NCT07245407Recruiting
Study of bronchiectasis types in Chinese patients
This study looks at different types of bronchiectasis in Chinese patients to understand the disease better. It may involve additional tests like lung function and questionnaires.
Beijing, Beijing MunicipalityAges Any age - NCT05793502Recruiting
Testing a heart pacing method with specific new devices
This trial studies how safe and effective a newer type of heart pacing (LBBaP) is when using two specific commercial devices. It may help people who are getting their first permanent pacemaker or heart-resynchronization treatment (CRT) by comparing outcomes after the procedure.
Taiyuan, ShanxiAges 18 years+ - NCT06670638Recruiting
New test for crohn's disease in people with a permanent ileostomy
This study aims to develop a new way to measure inflammation and symptoms in people with Crohn's disease who have a permanent ileostomy. Participants will undergo a routine ileoscopy and answer questions to help create better tools for future clinical trials.
Rochester, MinnesotaAges 18 years+ - NCT07606066Recruiting
Finding Type 2 Diabetes Patients for Future Research Studies
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
Little Rock, ArkansasAges 18 years+ - NCT06813339RecruitingEarly Phase 1
Testing a new drug in healthy people and those with heart condition
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
Adelaide, South AustraliaAges 18–79 - NCT06246409Recruiting
Better instructions for first-time radiation therapy patients
This study is testing a new way to give instructions to people having their first outpatient external beam radiation. It aims to help you better understand your treatment and follow the steps more easily.
Gainesville, FloridaAges 18–99 - NCT05692388Recruiting
Study social needs support for Black adults with kidney and diabetes
This study looks at health-related social needs—like barriers to food, housing, or care—in African American adults living with type 2 diabetes and chronic kidney disease. It uses a mixed-methods approach to understand needs better and what support may help.
Milwaukee, WisconsinAges 18 years+ - NCT06474169Recruiting
T-cell study in long-term kidney failure
This study is looking at how immune cells called T-cells work in people with long-term kidney failure. It tests whether these cells can be changed in the lab to help treat the condition.
OrléansAges 18 years+ - NCT07284121Recruiting
Patient satisfaction and safety of Atezolizumab in routine care
This study tracks how well Atezolizumab (Tecentriq) works for people with certain lung or liver cancers in everyday medical practice. It helps doctors understand if patients are satisfied with their treatment and how it affects their quality of life.
KremsAges 18 years+ - NCT00898638Recruiting
Tissue sample study for head and neck cancer patients and healthy people
This study collects tissue samples from people with head and neck cancer and from healthy volunteers. The samples help researchers better understand the disease and may support future tests or treatments.
Nashville, TennesseeAges 18 years+ - NCT04243356Enrolling by invitation
ICU nurse involvement in a post-ICU follow-up clinic
This study looks at whether having ICU nurses actively involved in a follow-up clinic after ICU discharge improves patients’ recovery and follow-up care. It focuses on patients who were cared for in the ICU and the registered nurses who cared for them.
Ann Arbor, MichiganAges 18 years+ - NCT07483827RecruitingPhase 1
Testing CPV-104 safety in healthy people and C3G patients
This trial tests a new drug called CPV-104. First, healthy volunteers will receive a single dose to check safety. Then, people with C3 glomerulopathy (a rare kidney disease) will receive multiple doses to see if it helps and is safe.
ViennaAges 18 years+ - NCT05733702Recruiting
Study of Crohn’s and ulcerative colitis treatment changes
This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.
LuxembourgAges 18 years+ - NCT07486947Recruiting
Studying nutrition and metabolism in lung cancer
This trial looks at how lung cancer and treatment affect your nutrition and metabolism. It aims to create a personalized nutrition plan for people with lung cancer.
Parma, ParmaAges 18–85 - NCT05978128Recruiting
Use advocates to boost lung cancer screening
This trial tests whether trained advocates and supporters can help people who are eligible for lung cancer screening actually get screened. It may help you (and others) by making screening easier to plan and complete.
Los Angeles, CaliforniaAges 40–80 - NCT07644702Recruiting
Community health forums to increase breast cancer screening
This study invites rural and low-income women to join free community forums that teach about breast cancer screening and clinical trials. The goal is to help more women get mammograms (breast X-rays) and learn about research opportunities that might benefit their health.
Eau Claire, WisconsinAges 50–74 - NCT06324396RecruitingPhase 1
Improving drug dosing for single ventricle patients with liver disease
This trial studies how the drugs sildenafil and pravastatin work in people with a single ventricle heart condition who have had the Fontan surgery and may have related liver problems. The goal is to find the best doses based on liver function.
Kansas City, MissouriAges 8 years+ - NCT06746623Recruiting
Non-endoscopic screening for Barrett's in veterans without reflux
This trial tests a new, non-endoscopic screening method for Barrett's esophagus (a condition that can lead to cancer) in veterans who do not have chronic acid reflux. It aims to find early signs of the condition using a simple swallowable device, potentially avoiding the need for a traditional endoscopy.
Cleveland, OhioAges 40–85 - NCT07445503Recruiting
High phenolic olive oil for metabolic health in central obesity
This trial tests whether a special olive oil rich in natural plant compounds (polyphenols) can improve metabolic health in people with belly fat. You may be eligible if you are an adult with overweight or obesity and have at least one related health issue like high blood pressure, high blood sugar, or abnormal cholesterol.
KalamataAges 18–80 - NCT07562620Recruiting
Video-Based Hand Therapy and Social Participation
This study tests whether watching educational videos about hand rehabilitation helps adults recover better and stay more socially active after hand surgery or injury. Researchers will compare this video approach with standard physical therapy.
Istanbul, IstanbulAges 18–65 - NCT05713669Recruiting
Clinic follow-up after ICU care with resident involvement
This study looks at whether having medical trainees (residents) participate in a follow-up clinic after an ICU stay affects patient care and follow-up. You may be eligible if you’re connected to the ICU follow-up clinic and had no death during your ICU stay.
Ann Arbor, MichiganAges 18 years+ - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT07512271Recruiting
AI Education Tool for Breast Cancer Patients
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
San Francisco, CaliforniaAges 18 years+
Hear when a new Patient Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient participation?
- Yes. Clin2 currently lists 85 recruiting patient participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.